Rapidly changing landscape of precision medicine in Japan

Rapidly changing landscape of precision medicine in Japan

Publication date: Jul 10, 2019

Dr Sadakatsu Ikeda speaks to ecancer at the WIN 2019 Symposium in Paris about the rapidly changing landscape of precision medicine in Japan.

He explains that there has been recent approval for access to comprehensive genomic profiling in Japan, with between 5000 and 20,000 people per year expected to be available for this data capture.

Dr Ikeda also discusses the difficulties in accessing drugs following genomic sequencing due to the possible treatments being ‘off-label’.

Sign up to ecancer for free to receive tailored email alerts for more videos like this.

ecancer.org/account/register.php

Concepts Keywords
Cat Care insurance
Clinical Trials Branches of biology
Cohort Life sciences
Critical Data Molecular biology
Diagnostic Test Biotechnology
Fighting Talk Clinical research
Genetic Sequencing DNA
Genomic Sequencing Clinical trial
Grass DNA sequencing
Insurance Whole genome sequencing
Japan Php
Japan National
Japanese Government
Jupiter
Mexican
National Insurance
Paris
Register
Sequencing
Tractor

Semantics

Type Source Name
gene UNIPROT ZNF746
gene UNIPROT SOX3
gene UNIPROT PHPT1
gene UNIPROT ASAH1

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *